Advanced Drug Delivery Reviews

Papers
(The H4-Index of Advanced Drug Delivery Reviews is 84. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Gene editing strategies to treat lysosomal disorders: The example of mucopolysaccharidoses757
Editorial board members395
Emerging antibiotic alternatives: From antimicrobial peptides to bacteriophage therapies314
Long-acting inhaled medicines: Present and future310
Recent advances in endocrine organoids for therapeutic application308
Liposomal formulations for treating lysosomal storage disorders299
Genome-scale metabolic modelling in antimicrobial pharmacology: Present and future274
MIDD in Japan– Implementations, challenges and opportunities262
Leveraging the neurosurgical operating room for therapeutic development in NeuroOncology252
Models to study basic and applied aspects of lysosomal storage disorders241
Tools for computational design and high-throughput screening of therapeutic enzymes201
MicroRNAs and their delivery in diabetic fibrosis201
Integrating microneedles and sensing strategies for diagnostic and monitoring applications: The state of the art198
Drug delivery for metabolism targeted cancer immunotherapy183
Penetration and translocation of functional inorganic nanomaterials into biological barriers179
Progress on the pathological tissue microenvironment barrier-modulated nanomedicine174
Opportunities and challenges in delivering biologics for Alzheimer’s disease by low-intensity ultrasound164
Deciphering albumin-directed drug delivery by imaging161
Polymer-based drug delivery systems under investigation for enzyme replacement and other therapies of lysosomal storage disorders161
Nanoparticle-neutrophils interactions for autoimmune regulation157
Nanovaccines with cell-derived components for cancer immunotherapy151
Nanoparticle designs for delivery of nucleic acid therapeutics as brain cancer therapies148
Bacterially mediated drug delivery and therapeutics: Strategies and advancements147
Emerging strategies to bypass transplant rejection via biomaterial-assisted immunoengineering: Insights from islets and beyond146
Drug delivery strategies in maximizing anti-angiogenesis and anti-tumor immunity145
Design, development and clinical translation of CriPec®-based core-crosslinked polymeric micelles141
In situ cellular hitchhiking of nanoparticles for drug delivery139
Cell membrane-coated nanoparticles for targeting carcinogenic bacteria139
Editorial Board139
Luminescent quantum dots: Synthesis, optical properties, bioimaging and toxicity139
Biomarker and therapeutic potential of peripheral extracellular vesicles in Alzheimer’s disease136
Nanoparticles-mediated ion channels manipulation: From their membrane interactions to bioapplications135
Targeting microbiome, drug metabolism, and drug delivery in oncology131
Editorial/Preface128
From cells to subcellular organelles: Next-generation cancer therapy based on peptide self-assembly126
Protein encapsulation of nanocatalysts: A feasible approach to facilitate catalytic theranostics124
3D printing of drug delivery systems enhanced with micro/nano-technology123
Pulmonary delivery nanomedicines towards circumventing physiological barriers: Strategies and characterization approaches123
Activatable fluorescent probes for real-time imaging-guided tumor therapy121
Emerging Voices in Drug Delivery – Harnessing and Modulating Complex Biological Systems (Issue 2)119
Activatable dual-functional molecular agents for imaging-guided cancer therapy116
RNA binding proteins (RBPs) and their role in DNA damage and radiation response in cancer115
Exosome- and extracellular vesicle-based approaches for the treatment of lysosomal storage disorders115
Synthetic biology-guided design and biosynthesis of protein polymers for delivery115
Novel strategies for modulating the gut microbiome for cancer therapy114
Biopharmaceutical drug delivery and phototherapy using protein crystals113
Ultrasonic particles: An approach for targeted gene delivery112
Drug development of lyso-thermosensitive liposomal doxorubicin: Combining hyperthermia and thermosensitive drug delivery111
Solid implantable devices for sustained drug delivery110
Strategies to develop polymeric microneedles for controlled drug release108
Drug delivery using gold nanoparticles108
Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers108
Lysosomal therapies and drug delivery strategies: An overview105
Unignored intracellular journey and biomedical applications of extracellular vesicles104
Tumour extravasation of nanomedicine: The EPR and alternative pathways102
Soft nano and microstructures for the photomodulation of cellular signaling and behavior101
Technological and translational challenges for extracellular vesicle in therapy and diagnosis99
Hurdles in translating science from lab to market in delivery systems for Cosmetics: An industrial perspective99
The extracellular matrix of hematopoietic stem cell niches99
In-vitro 3D modelling for charged particle therapy – Uncertainties and opportunities97
Light sheet fluorescence microscopy for monitoring drug delivery: Unlocking the developmental phases of embryos96
Micro-patterned cell populations as advanced pharmaceutical drugs with precise functional control96
Emerging drug delivery systems with traditional routes – A roadmap to chronic inflammatory diseases96
Tumor microenvironment subtyping in pancreatic ductal adenocarcinoma: New avenues for personalized therapeutic strategies95
Model-informed precision dosing: State of the art and future perspectives95
Miniaturized therapeutic systems for ultrasound-modulated drug delivery to the central and peripheral nervous system95
Novel drug delivery systems for the management of dry eye94
Modular design principle based on compartmental drug delivery systems94
Fit and forget: The future of dental implant therapy via nanotechnology91
Engineering complexity in human tissue models of cancer90
Overcoming therapy resistance in pancreatic cancer: challenges and emerging strategies90
Antibody-drug conjugates as multimodal therapies against hard-to-treat cancers89
Nanobodies: Robust miniprotein binders in biomedicine89
Advances in photoactivated carbon-based nanostructured materials for targeted cancer therapy89
Convection-enhanced delivery for brain malignancies: Technical parameters, formulation strategies and clinical perspectives89
To PEGylate or not to PEGylate: Immunological properties of nanomedicine’s most popular component, polyethylene glycol and its alternatives88
Nanosensitizer-mediated unique dynamic therapy tactics for effective inhibition of deep tumors88
Engineering bacterial membrane nanovesicles for improved therapies in infectious diseases and cancer88
Lipid nanoparticles for targeted delivery of anticancer therapeutics: Recent advances in development of siRNA and lipoprotein-mimicking nanocarriers87
Preface: Image-assisted organoid research and application86
Corrigendum to “Editorial: Advanced strategies to bridge the gap between inflammation and tissue regeneration” [Adv. Drug Deliv. Rev. 209 (2024) 115328]86
Editorial Board85
Modulating tumor physical microenvironment for fueling CAR-T cell therapy84
Gelatin-integrated carbon nanomaterials in nanomedicine: From biosensing and bioprinting to tissue engineering and other biomedical applications84
0.33167195320129